FDA plans to keep Makary priorities on trials, China, deputy says

June 15, 2026 02:53 PM EDT FDA+ Chi­na, rare dis­eases and af­ford­abil­i­ty: How rid­ers in Con­gress may shape FDA's user fees Zachary Brennan Senior Editor PHILADEL­PHIA – Fol­low­ing the re­cent de­par­tures of FDA Com­mis­sion­er Mar­ty Makary and both of his cen­ter di­rec­tors for drugs and bi­o­log­ics, the Trump ad­min­is­tra­tion will … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER